Here, we report the case of a 53-year-old man with EGFR L858R-mutant stage IV lung adenocarcinoma who developed multifocal progression involving the lungs, liver, bones, and brain after multiple prior treatments. This evidence concerns the gene EGFR and lung adenocarcinoma.